Alzheimer's Disease
Alzheimer's disease (AD) is a progressive neurological disorder that leads to memory loss, cognitive decline, and changes in behavior, significantly impacting daily life.
Alzheimer’s Disease: Trontinemab Study
We are assessing how a new monoclonal antibody, Trontinemab, behaves in the brains of healthy individuals and those with Alzheimer’s disease. This study aims to understand its distribution and retention in the brain.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Stichting Amsterdam UMC
Department of Radiology and Nuclear Medicine
Amstelveen, Netherlands
Sponsor: F. Hoffmann-La Roche AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.